Cost implications of testing strategy in patients with syncope: Randomized assessment of syncope trial

Journal of the American College of Cardiology

Volumn 42, Issue 3, 2003, Pages 495-501

  Krahn, Andrew D ^a,b   Klein, George J ^a   Yee, Raymond ^a   Hoch, Jeffrey S ^a   Skanes, Allan C ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; CROSSOVER PROCEDURE; DIAGNOSTIC ACCURACY; FEMALE; HEALTH CARE COST; HEART FUNCTION TEST; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTATION; MALE; MONITORING; PATIENT; PRIORITY JOURNAL; RANDOMIZATION; RECORDER; SYNCOPE; TILTING;

EID: 0042490666     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00659-4     Document Type: Article

References (33)

1. Kapoor WN, Karpf M, Wieand S, Peterson JR, Levey GS. A prospective evaluation and follow-up of patients with syncope. N Engl J Med 1983;309:197-204.
2. Kapoor WN, Hammill SC, Gersh BJ. Diagnosis and natural history of syncope and the role of invasive electrophysiologic testing. Am J Cardiol 1989;63:730-4.
3. Sra JS, Anderson AJ, Sheikh SH, et al. Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing. Ann Intern Med 1991;114:1013-9.
4. Manolis AS, Linzer M, Salem D, Estes NA. Syncope: current diagnostic evaluation and management. Ann Intern Med 1990;112:850-63.
5. Linzer M, Yang EH, Estes NA, Wang P, Vorperian VR, Kapoor WN. Diagnosing syncope. Part 2: unexplained syncope: Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 1997;127:76-86.
6. Brown AP, Dawkins KD, Davies JG. Detection of arrhythmias: use of a patient-activated ambulatory electrocardiogram device with a solid-state memory loop. Br Heart J 1987;58:251-3.
7. Linzer M, Prystowsky EN, Brunetti LL, Varia IM, German LD. Recurrent syncope of unknown origin diagnosed by ambulatory continuous loop ECG recording. Am Heart J 1988;116:1632-4.
8. Linzer M, Pritchett EL, Pontinen M, McCarthy E, Divine GW. Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope. Am J Cardiol 1990;66:214-9.
9. Cumbee SR, Pryor RE, Linzer M. Cardiac loop ECG recording: a new noninvasive diagnostic test in recurrent syncope. South Med J 1990;83:39-43.
10. Krahn AD, Klein GJ, Yee R, Norris C. Final results from a pilot study with an implantable loop recorder to determine the etiology of syncope in patients with negative noninvasive and invasive testing. Am J Cardiol 1998;82:117-9.
11. Krahn AD, Klein GJ, Yee R, Takle-Newhouse T, Norris C, the REVEAL Investigators. Use of an extended monitoring strategy in patients with problematic syncope. Circulation 1999;99:406-10.
12. Krahn AD, Klein GJ, Fitzpatrick A, et al. Predicting the outcome of patients with unexplained syncope undergoing prolonged monitoring. Pacing Clin Electrophysiol 2002;25:37-41.
13. Krahn AD, Klein GJ, Yee R, Skanes AC. Randomized Assessment of Syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 2001;104:46-51.
14. Klein GJ, Gersh BJ, Yee R. Electrophysiological testing: the final court of appeal for diagnosis of syncope? Circulation 1995;92:1332-5.
15. Morillo CA, Klein GJ, Zandri S, Yee R. Diagnostic accuracy of a low-dose isoproterenol head-up tilt protocol. Am Heart J 1995;129:901-6.
16. Krahn AD, Klein GJ, Yee R, Norris C. Maturation of the sensed electrogram amplitude over time in a new subcutaneous implantable loop recorder. Pacing Clin Electrophysiol 1997;20:1686-90.
17. Krahn AD, Klein GJ, Norris C, Yee R. The etiology of syncope in patients with negative tilt table and electrophysiological testing. Circulation 1995;92:1819-24.
18. Seidl K, Rameken M, Breunung S, et al., the REVEAL Investigators. Diagnostic assessment of recurrent unexplained syncope with a new subcutaneously implantable loop recorder. Europace 2000;2:256-62.
19. Benditt DG, Ferguson DW, Grubb BP, et al. Tilt table testing for assessing syncope. J Am Coll Cardiol 1996;28:263-75.
20. Kapoor WN, Smith MA, Miller NL. Upright tilt testing in evaluating syncope: a comprehensive literature review. Am J Med 1994;97:78-88.
21. Sutton R, Bloomfield DM. Indications, methodology, and classification of results of tilt-table testing. Am J Cardiol 1999;84:10-9Q.
22. Zipes DP, DiMarco JP, Gillette PC, et al. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 1995;26:555-73.
23. Bachinsky WB, Linzer M, Weld L, Estes NA. Usefulness of clinical characteristics in predicting the outcome of electrophysiologic studies in unexplained syncope. Am J Cardiol 1992;69:1044-9.
24. Simpson CS, Badow MA, Krahn AD, Klein GJ, Yee R, Skanes AC. Recurrent seizure diagnosed by the insertable loop recorder (ILR). J Intervent Card Electrophysiol 2000;4:475-9.
25. Andrews NP, Fogel RI, Pelargonio G, Evans JJ, Prystowsky EN. Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias: a comparison with patients known to have sustained ventricular tachycardia. J Am Coll Cardiol 1999;34:2023-30.
26. Fonarow GC, Feliciano Z, Boyle NG, et al. Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator. Am J Cardiol 2000;85:981-5.
27. LeLorier P, Krahn AD, Klein GJ, Yee R, Skanes AC. Comparison of patients with syncope with left ventricular dysfunction and negative electrophysiologic testing to cardiac arrest survivors and patients with syncope and preserved left ventricular function and impact of an implantable defibrillator. Am J Cardiol 2002;90:77-9.
28. Link MS, Costeas XF, Griffith JL, Colburn CD, Estes NA, Wang PJ. High incidence of appropriate implantable cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular arrhythmias. J Am Coll Cardiol 1997;29:370-5.
29. Militianu A, Salacata A, Seibert K, et al. Implantable cardioverter defibrillator utilization among device recipients presenting exclusively with syncope or near-syncope. J Cardiovasc Electrophysiol 1997;8:1087-97.
30. Mittal S, Iwai S, Stein KM, Markowitz SM, Slotwiner DJ, Lerman BB. Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era. J Am Coll Cardiol 1999;34:1082-9.
31. Krahn AD, Klein GJ, Yee R, Manda V. The high cost of syncope: cost implications of a new insertable loop recorder in the investigation of recurrent syncope. Am Heart J 1999;137:870-7.
32. Simpson CS, Krahn AD, Klein GJ, et al. A cost effective approach to the investigation of syncope: relative merit of different diagnostic strategies. Can J Cardiol 1999;15:579-84.
33. Calkins H, Byrne M, el-Atassi R, Kalbfleisch S, Langberg JJ, Morady F. The economic burden of unrecognized vasodepressor syncope. Am J Med 1993;95:473-9.